| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 224 |
| 1 | PEMBROLIZUMAB | 191 |
| 2 | IPILIMUMAB | 186 |
| 3 | CARBOPLATIN | 97 |
| 4 | PACLITAXEL | 64 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 63 |
| 6 | CYCLOPHOSPHAMIDE | 41 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 41 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 41 |
| 9 | BEVACIZUMAB | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPILIMUMAB | 186 | 0.0042 |
| 1 | TREMELIMUMAB | 13 | 0.0029 |
| 2 | NIVOLUMAB | 224 | 0.0023 |
| 3 | PEMBROLIZUMAB | 191 | 0.0018 |
| 4 | EPIRUBICIN HYDROCHLORIDE | 11 | 0.0017 |
| 5 | DURVALUMAB | 17 | 0.0008 |
| 6 | CARBOPLATIN | 97 | 0.0007 |
| 7 | PACLITAXEL | 64 | 0.0006 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| 9 | LENVATINIB | 15 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 414 | 0.0042 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 199 | 0.0041 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 17 | 0.0008 |
| 3 | Platinum-based Drug [EPC] | 116 | 0.0004 |
| 4 | Microtubule Inhibitor [EPC] | 68 | 0.0004 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 6 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 7 | Alkylating Drug [EPC] | 42 | 0.0002 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 9 | Penem Antibacterial [EPC] | 4 | 0.0001 |